ASP0892 (ARA-LAMP-vax)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ASP0892 (ARA-LAMP-vax), covering 2024-10-23 to 2024-10-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Safety, Tolerability and Immune Response in Adults Allergic to Peanut After Receiving Intradermal or Intramuscular Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine [Phase 1]